Junlin Lu
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Author Correction - with Update (U+C): Miniature and versatile genome regulation TnpB-ωRNA toolkits facilitate cancer immunotherapy.
Journal: Nature communications
Published: September 03, 2026
Targeting TPX2-dependent lineage plasticity by CDK4/6 inhibition reverses therapy resistance in neuroendocrine bladder carcinoma.
Journal: Cell reports. Medicine
Published: December 05, 2025
Miniature and versatile genome regulation TnpB-ωRNA toolkits facilitate cancer immunotherapy.
Journal: Nature communications
Published: September 11, 2025
A Multifunctional Fe-EGCG@RSL3 Nanomedicine Synergizes Ferroptosis Induction and Tumor Microenvironment Remodeling for Enhanced Bladder Cancer Immunotherapy.
Journal: Research (Washington, D.C.)
Published: April 17, 2025
Engineering CRISPR System-Based Bacterial Outer Membrane Vesicle Potentiates T Cell Immunity for Enhanced Cancer Immunotherapy.
Journal: Advanced materials (Deerfield Beach, Fla.)
Published: January 22, 2025
Reprogramming the tumor microenvironment with c-MYC-based gene circuit platform to enhance specific cancer immunotherapy.
Journal: Nature communications
Published: December 19, 2024
Advancements in genetic circuits as part of intelligent biotherapy for the treatment of bladder cancer: A review.
Journal: Bladder (San Francisco, Calif.)
Published: October 08, 2024
PTBP1 Regulates DNMT3B Alternative Splicing by Interacting With RALY to Enhance the Radioresistance of Prostate Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: May 31, 2024
A clinically practical model for the preoperative prediction of lymph node metastasis in bladder cancer: a multicohort study.
Journal: British journal of cancer
Published: March 05, 2023
ETV4 Mediated Tumor-Associated Neutrophil Infiltration Facilitates Lymphangiogenesis and Lymphatic Metastasis of Bladder Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: September 27, 2022
NAT10 Drives Cisplatin Chemoresistance by Enhancing ac4C-Associated DNA Repair in Bladder Cancer.
Journal: Cancer research
Published: July 12, 2022
Last Updated: 09/26/2026